Impaired phagocytosis and susceptibility to infection in pediatric-onset systemic lupus erythematosus

Lupus

Volumn 22, Issue 3, 2013, Pages 279-288

  Wu, S A ^a   Yeh, K W ^a   Lee, W I ^a   Yao, T C ^a   Kuo, M L ^b   Huang, B ^c   Huang, J L ^a,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

children; innate immunity; phagocytosis; polymorphonuclear cells; Salmonella infection; Systemic lupus erythematosus

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOSUPPRESSIVE AGENT; PEROXIDASE;

ADOLESCENT; ARTICLE; CHEMOTAXIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; INFECTION SENSITIVITY; MALE; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SALMONELLA; SALMONELLOSIS; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; BACTERIAL INFECTIONS; CHILD; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPOPOLYSACCHARIDES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NEUTROPHILS; PHAGOCYTOSIS; SALMONELLA; SALMONELLA INFECTIONS;

EID: 84874434432     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312474704     Document Type: Article

References (40)

1. Martin H, Reinhard E, Otmar M, et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived by macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998 ; 41: 1241-1250
2. Taylor PR, Carugati A, Fadok VA, et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med. 2000 ; 192: 359-366
3. Rosen A, Casciola-Rosen L. Auto-antigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 1999 ; 6: 6-12
4. Huang JL, Yeh KW, Yao TC, et al. Pediatric lupus in Asia. Lupus. 2010 ; 19: 1414-1418
5. Tsao CH, Chen CY, Ou LS, et al. Risk factors of mortality for salmonella infection in systemic lupus erythematosus. J Rheumatol. 2002 ; 29: 1214-1218
6. Wu KC, Yao TC, Yeh KW, Huang JL. Osteomyelitis in patients with systemic lupus erythematosus. J Rheumatol. 2004 ; 31: 1340-1343
7. Huang JL, Lin GJ, Hung IJ. Morbidity and mortality associated with childhood systemic lupus erythematosus. Chang Gung Med J. 1994 ; 17: 113-120
8. Chen MJ, Tseng HM, Huang YL, et al. Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteremia episodes: 6-yr follow-up. Rheumatology. 2008 ; 47: 1352-1357
9. Hung JJ, Ou LS, Lee WI, Huang JL. Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol. 2005 ; 32: 40-43
10. Huang JL, Hung JJ, Wu KC, et al. Septic arthritis in patients with systemic lupus erythematosus: Salmonella and non-salmonella infections compared. Semin Arthritis Rheum. 2006 ; 36: 61-67
11. Lekstrom-Himes JA, Gallin JI. Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med. 2000 ; 343: 1703-1703
12. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
13. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
14. Yu HR, Chang JC, Chen RF, et al. Different antigens trigger different Th1/Th2 reactions in neonatal mononuclear cells (MNCs) relating to T-bet/GATA-3 expression. J Leukoc Biol. 2003 ; 74: 952-958
15. Drevets DA, Campbell PA. Macrophage phagocytosis: Use of fluorescence microscopy to distinguish between extracellular and intracellular bacteria. J Immunol Methods. 1991 ; 142: 31-38
16. Szejda P, Parce JW, Seeds MS, Bass DA. Flow cytometric quantitation of oxidative product formation by polymorphonuclear leukocytes during phagocytosis. J Immunol. 1984 ; 133: 3303-3307
17. Oben JA, Foreman JC. A simple quantitative fluorimetric assay of in vitro phagocytosis in human neutrophils. J Immunol Methods. 1988 ; 112: 99-103
18. White-Owen C, Alexander JW, Sramkoski RM, Babcock GF. Rapid whole-blood micro-assay using flow cytometry for measuring neutrophil phagocytosis. J Clin Microbiol. 1992 ; 30: 2071-2076
19. Katz SS, Weinrauch Y, Munford RS, Elsbach P, Weiss J. Deacylation of lipopolysaccharide in whole Escherichia coli during destruction by cellular and extracellular components of a rabbit peritoneal inflammatory exudate. J Biol Chem. 1999 ; 274: 36579-36584
20. Rosenzweig SD, Holland SM. Phagocyte immuno-deficiencies and their infections. J Allergy Clin Immunol. 2004 ; 113: 620-626
21. Janko C, Schorn C, Grossmayer GE, Munoz LE. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE). Autoimmun Rev. 2008 ; 8: 9-12
22. Landry M. Phagocyte function and cell-mediated immunity in systemic lupus erythematosus. Arch Dermatol. 1977 ; 113: 147-154
23. Iliopoulos AG, Tsokos GC. Immuno-pathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum. 1996 ; 25: 318-336
24. Yi Ren, Tang JL, Mok MY, et al. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum. 2003 ; 10: 2888-2897
25. Hsieh SC, Tsai CY, Sun KH, et al. Decreased spontaneous and lipopolysaccharide stimulated production of interleukin 8 by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus. Clin Exp Rheumatol. 1994 ; 12: 627-633
26. Svenssou BO. Serum factors causing impaired macrophage function in systemic erythematosus. Scand J lmmunol. 1975 ; 4: 145-150
27. Vazquez Doval J, Sanchez Tbarrola A. Defective mononuclear phagocyte function in systemic lupus erythematosus: relationship of FcRII (CD32) with intermediate cytoskeletal filaments. J lnvestig Allergol Clin Immunol. 1993 ; 3: 86-91
28. Passero FC, Myers AR. Decreased numbers of monocytes in inflammatory exudates in systemic lupus erythematosus. J Rheumatol. 1981 ; 8: 62-68
29. Ishikawa O, Abe M, Miyachi Y. Herpes zoster in Japanese patients with systemic lupus erythematosus. Clin Exp Dermatol. 1999 ; 24: 327-328
30. Kahl LE. Herpes zoster infections in systemic lupus erythematosus: Risk factors and outcome. J Rheumatol. 1994 ; 21: 84-86
31. Kang I, Park SH. Infectious complications in SLE after immuno-suppressive therapies. Curr Opin Rheumatol. 2003 ; 15: 528-534
32. Pablos JL, Aragon A, Gomez-Reino JJ. Salmonellosis and systemic lupus erythematosus. Report of ten cases. Br J Rheumatol. 1994 ; 33: 129-132
33. de Luis A, Pigrau C, Pahissa A, Fernandez F, Martinez-Vazquez JM. Infections in 96 cases of systemic lupus erythematosus. Med Clin. 1990 ; 94: 607-610
34. Lim E, Koh WH, Loh SF, et al. Non-thyphoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus. 2001 ; 10: 87-92
35. Abramson S, Kramer SB, Radin A, Holzman R. Salmonella bacteremia in systemic lupus erythematosus. Eight-year experience at a municipal hospital. Arthritis Rheum. 1985 ; 28: 75-79
36. Noël V, Lortholary O, Casassus P, et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis. 2001 ; 60: 1141-1144
37. Insoo K, Park SH. Infectious complications in SLE after immuno-suppressive therapies. Current Opinion in Rheumatol. 2003 ; 15: 528-534
38. Manzi S, Kuller LH, Kutzer J, et al. Herpes zoster in systemic lupus erythematosus. J Rheumatol. 1995 ; 22: 1254-1258
39. Illei GG, Austin HA, Crane M, et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med. 2001 ; 135: 248-257
40. Ginzler E, Diamond H, Kaplan D, et al. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 1978 ; 21: 37-44